Related Experiment Video
Updated: Feb 28, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Treatment of Cervical Artery Dissection: Antithrombotics, Thrombolysis, and Endovascular Therapy
Jing Peng1, Zunjing Liu2, Chunxia Luo1
1Department of Neurology of Southwest Hospital, Third Military Medical University, No. 30 Gaotanyan Road, Chongqing 400038, China.
Insights
Cervical artery dissection (CAD) is a leading cause of stroke in young adults. Treatment focuses on preventing further damage and restoring blood flow, with antithrombotic therapy being crucial but its optimal strategy remaining unclear.
Area of Science:
- Neurology
- Vascular Medicine
- Cardiovascular Research
Background:
- Cervical artery dissection (CAD) is a significant cause of stroke in patients under 45, contributing to 5-22% of cases.
- CAD can result in diverse neurological complications, including neuropathy, ischemic stroke, and subarachnoid hemorrhage.
- The condition has a natural tendency towards self-healing, necessitating individualized treatment approaches based on clinical presentation.
Purpose of the Study:
- To outline treatment strategies for cervical artery dissection (CAD).
- To emphasize the importance of managing CAD-induced neurological damage and restoring cerebral blood flow.
- To review current drug and endovascular treatment options for CAD.
Main Methods:
- Discussion of drug therapies, including antiplatelet and anticoagulant agents, for stroke risk reduction in CAD.
- Exploration of endovascular treatment modalities for CAD.
- Analysis of the current understanding of antithrombotic therapy effectiveness and endovascular treatment timing.
Main Results:
- Antithrombotic treatment is a critical component of managing cervical artery dissection (CAD).
- The comparative efficacy of antiplatelet versus anticoagulant therapy for stroke risk reduction in CAD is not yet established.
- The optimal timing and efficacy of endovascular interventions for CAD are subjects of ongoing debate and research.
Conclusions:
- Treatment for cervical artery dissection (CAD) must be tailored to individual clinical manifestations.
- Further research is needed to determine the most effective antithrombotic strategy and the role of endovascular treatment in CAD management.
- Optimizing treatment for CAD is essential to reduce the significant burden on patients, families, and society.
Abstract:
Cervical artery dissection (CAD) is an important cause of stroke for young patients, accounting for 5-22% of strokes in patients <45 years of age, which presents not only a great burden to the stroke victims but also a financial burden to the family and society. Because CAD can lead to different clinical lesions, including neuropathy, acute ischemic stroke, and subarachnoid hemorrhage, and is an arterial dissection with a self-healing tendency, the treatment options depend on the clinical manifestations. The main purpose of the treatment is to control CAD-induced neuronal damage and to restore blood flow. The treatment programs include drug treatment and endovascular treatment. However, antithrombotic treatment is crucial. Both antiplatelet drugs and anticoagulant drugs are used to reduce the risk of stroke, but whether one treatment strategy is more effective than the other is unknown. The efficacy and timing of the endovascular treatment of CAD remain controversial.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
